Share this
overcoming hematocrit accuracy issues: VAMS vs. DBS
by Neoteryx Microsampling on Mar 6, 2018 1:32:52 PM
Overcoming the hematocrit (HCT) effect has for years been a major challenge to widespread adoption of dried blood spot (DBS) sampling technology. Is there a way to overcome the hematocrit bias with DBS or other blood microsampling technologies and get results on par with those generated from wet blood?
Volumetric Microsampling Overcomes the Hematocrit Bias
A breakthrough in medical technology, volumetric absorptive microsampling improves the the DBS approach to microsampling by enabling the collection of a fixed volume of blood. Volumetric microsampling can also reduce the costs of blood sample handling and shipping, because the collected specimens are dried blood samples that remain viable at ambient temperatures.
Mitra® devices with patented VAMS® technology makes it possible to draw fixed volume blood samples of 10, 20 and 30 µL (microliters) from a single finger prick. This method is less invasive than venipuncture methods that draw blood volumes approximately one thousand times greater.
Hematocrit Accuracy in Dried Blood Spot Microsampling
Dried Blood Spot (DBS) sampling has been utilized for decades to assess the blood chemistry of infants whose blood supply will not support conventional venipuncture sampling. With DBS, a drop of blood drawn from the infant’s finger or heel is placed on a specially treated filter paper (Guthrie or Whatman) or card for analysis.
Similarly, a Mitra® device with its absorptive VAMS® tip enables a quick blood draw with a finger-stick using a small lancet. The resulting microsamples will be processed as a type of DBS sample, requiring no refrigeration for storage and transport.
Lab analyses have shown that one critical variation exists in standard DBS evaluation: results of blood hematocrit levels, the volume of red blood cells as a percentage of the sample, can be misleading.
With traditional DBS, a blood spot is placed on a filter card and allowed to spread. How far the blood sample spreads will depend on the viscosity of the blood. If the blood spreads slowly, the viscosity is higher. If it spreads quickly, the viscosity is lower as the blood is somewhat thinner.
The existing level of hematocrit analyzed in a sample may vary due to a patient’s body hydration level. Lower viscosity, or more hydrated blood samples, spread further across the dried blood paper. In the lab, when the target blood sample area is punched from the DBS sample card, the analysis can result in a lower percentage of red blood cells or hematocrit. Smaller, more viscous samples will show a comparatively higher hematocrit level. These variations between samples can cause inconsistencies in the analytical data.
As a solution, perforating the DBS cards or adding wax to the DBS cards had the effect of limiting the blood spreading and better defining the area the spot covers. This results in a fixed volume and more accurate hematocrit level reading. The first method is called “whole spot analysis, perforated, and precut.” The second method is called "patterned DBS, or "pDBS."
But the best innovation was yet to come.
The VAMS Advantage
The VAMS method has emerged as the most promising solution yet to the problem of hematocrit bias in DBS sample collection. The Mitra device with a VAMS tip absorbs a precise volume of blood without regard to the viscosity, within seconds. When the sample is dried, the remaining volume delivers an accurate hematocrit reading without the variability of DBS.
Also, dried blood microsamples do not require refrigeration or special handling. The Mitra device is designed for easy sampling by anyone, anywhere. For many research studies, participants have successfully self-collected their samples at home or in other remote locations.
In the laboratory, sophisticated equipment and techniques can analyze microsamples as accurately as liquid blood samples or larger specimen samples.
If you haven't yet explored the advantages of volumetric microsampling technology, reach out to a microsampling specialist to discuss the possibilities:
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (2)